Tenderfy

Suministro de medicamentos exclusivos con principios activos belimumab, mepolizumab, niraparib y momelotinib del laboratorio glaxosmithkline, s.a

Buyer
Servicio Murciano de Salud - Junta de Compras
Published
2026-11-11
Deadline
Not provided
Sources
TED
Value
Not provided

Description

The description is in the source language.

Suministro de medicamentos exclusivos con principios activos belimumab, mepolizumab, niraparib y momelotinib del laboratorio Glaxosmithkline, s.a

CPV: 33652000, 33652100, 33652300, 33673000

Membership

Read notice previews free of charge. Official notice and document links, construction permits and personal MCP access require an active paid membership.

Read